Ballicules.com

Metolazone

ZAROXOLYN

What it isNCC-inhibiting thiazide-like diuretic; refractory edema in heart failure and kidney disease.

Why this oneIts pronounced synergy with loop diuretics makes it a rescue for diuretic-resistant edema even at low GFR.

What limits itThe combined diuresis can be profound — check electrolytes and volume within days. It is not interchangeable with other thiazides.

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Edema of cardiac failureAdult5–20 mg QD
Edema of renal diseaseAdult5–20 mg QD
Mild–moderate essential hypertensionAdult2.5–5 mg QD

Renal Undefined (contraindicated in anuria)

Hepatic Undefined (contraindicated in hepatic coma/precoma)

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Use only if clearly needed; crosses placenta; risk of fetal/neonatal jaundice and thrombocytopenia

Lactation Undefined

⚠ BOXED WARNING

Principal riskProfound diuresis and electrolyte loss when added to a loop diuretic

Cost, est. cash$5–$150/month

Generic entry2003

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Overdose danger2 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk2 / 4

Legacy pregnancy categoryC

Defining liabilityVolume depletion and electrolyte disturbances; kidney function and interacting medications modify risk.

Mechanism of action: Metolazone ballicule

Metolazone ballicule: receptor binding, kinetics and half-life diagram

Open Metolazone in the interactive console ↗

Memory aids: mascots and interaction avatars

Metolazone ZAROXOLYN mascot mnemonic cartoon
“Xeroxin’ Me to laser zone”
Bananas dispersing → ↓ serum potassium
Metolazone Box: minimal PK interactions avatar
Box: minimal PK interactions

Open Metolazone in the interactive console ↗